前收市價 | 18.10 |
開市 | 無 |
買盤 | 20.30 |
賣出價 | 22.10 |
拍板 | 17.50 |
到期日 | 2024-07-19 |
今日波幅 | 18.10 - 18.10 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 2 |
Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.